outsourcing trends for active pharmaceutical ingredient manufacturers

The active pharmaceutical ingredient manufacturers landscape is undergoing a significant transformation, characterized by a strategic and sustained shift towards outsourcing. API manufacturers are increasingly relying on Contract Development and Manufacturing Organizations (CDMOs) to enhance flexibility, reduce costs, and accelerate time-to-market. This trend is reshaping the global...